FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Brüss

Research Profile

Chemicals & Drugs

Physiology

Transfection

Concepts & Ideas

Molecular Sequence Data

Procedures

Anatomy

Genes & Molecular Sequences

Amino Acid Sequences

Living Beings

Rats

Co-author Network

Publications

TOP 3
Johannes Kapeller; Dorothee Möller; Felix Lasitschka; Frank Autschbach; Ruud Hovius; Gudrun Rappold; Michael Brüss; Michael D Gershon; Beate Niesler
Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.
Jutta Walstab; Folkert Steinhagen; Michael Brüss; Manfred Göthert; Heinz Bönisch
Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.
Jutta Walstab; Christian Hammer; Felix Lasitschka; Dorothee Möller; Christopher N Connolly; Gudrun Rappold; Michael Brüss; Heinz Bönisch; Beate Niesler
RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Brüss (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Johannes Kapeller; Dorothee Möller; Felix Lasitschka; Frank Autschbach; Ruud Hovius; Gudrun Rappold; Michael Brüss; Michael D Gershon; Beate Niesler
Serotonin receptor diversity in the human colon: Expression of serotonin type 3 receptor subunits 5-HT3C, 5-HT3D, and 5-HT3E.
The Journal of comparative neurology 2011;519(3):420-32.
2011: Jutta Walstab; Folkert Steinhagen; Michael Brüss; Manfred Göthert; Heinz Bönisch
Differences between human wild-type and C23S variant 5-HT2C receptors in inverse agonist-induced resensitization.
Pharmacological reports : PR 2011;63(1):45-53.
2010: Jutta Walstab; Christian Hammer; Felix Lasitschka; Dorothee Möller; Christopher N Connolly; Gudrun Rappold; Michael Brüss; Heinz Bönisch; Beate Niesler
RIC-3 exclusively enhances the surface expression of human homomeric 5-hydroxytryptamine type 3A (5-HT3A) receptors despite direct interactions with 5-HT3A, -C, -D, and -E subunits.
The Journal of biological chemistry 2010;285(35):26956-65.
2009: Britta Haenisch; Karoline Linsel; Michael Brüss; Ralf Gilsbach; Peter Propping; Markus M Nöthen; Marcella Rietschel; Rolf Fimmers; Wolfgang Maier; Astrid Zobel; Susanne Höfels; Vera Guttenthaler; Manfred Göthert; Heinz Bönisch
Association of major depression with rare functional variants in norepinephrine transporter and serotonin1A receptor genes.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2009;150B(7):1013-6.
2009: Sandra Combrink; Arevat Kostanian; Jutta Walstab; Martin Barann; Michael Brüss; Manfred Göthert; Heinz Bönisch
Characterization of the naturally occurring Arg344His variant of the human 5-HT 3A receptor.
Pharmacological reports : PR 2009;61(5):785-97.
2007: Gerhard J Molderings; Heinz Bönisch; Michael Brüss; Christiana Wolf; Ivar von Kügelgen; Manfred Göthert
S1P-receptors in PC12 and transfected HEK293 cells: molecular targets of hypotensive imidazoline I(1) receptor ligands.
Neurochemistry international 2007;51(8):476-85.
2007: Andrea Muck; Ralf Gilsbach; Sandra Löbbe-Werner; Michael Brüss; Heinz Bönisch
Molecular cloning and functional expression of the murine noradrenaline transporter.
Naunyn-Schmiedeberg's archives of pharmacology 2007;376(1-2):65-71.
2007: Jutta Walstab; Sandra Combrink; Michael Brüss; Manfred Göthert; Beate Niesler; Heinz Bönisch
Aequorin luminescence-based assay for 5-hydroxytryptamine (serotonin) type 3 receptor characterization.
Analytical biochemistry 2007;368(2):185-92.
2007: Gerhard J Molderings; Ulrich W Kolck; Christian Scheurlen; Michael Brüss; Jürgen Homann; Ivar von Kügelgen
Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder.
Scandinavian journal of gastroenterology 2007;42(9):1045-53.
2007: Beate Niesler; Jutta Walstab; Sandra Combrink; Dorothee Möller; Johannes Kapeller; Jens Rietdorf; Heinz Bönisch; Manfred Göthert; Gudrun Rappold; Michael Brüss
Characterization of the novel human serotonin receptor subunits 5-HT3C,5-HT3D, and 5-HT3E.
Molecular pharmacology 2007;72(1):8-17.
2007: C Wolf; Michael Brüss; B Hänisch; Manfred Göthert; Ivar von Kügelgen; Gerhard J Molderings
Molecular basis for the antiproliferative effect of agmatine in tumor cells of colonic, hepatic, and neuronal origin.
Molecular pharmacology 2007;71(1):276-83.
2006: Gerhard J Molderings; Ulrich W Kolck; C Scheurlen; Michael Brüss; T Frieling; M Raithel; Jürgen Homann
[Systemic mast cell disease with gastrointestinal symptoms--a diagnostic questionnaire].
Deutsche medizinische Wochenschrift (1946) 2006;131(38):2095-100.
2006: Raphaela Verheggen; Inga Werner; Anne Lücker; Michael Brüss; Manfred Göthert; Alberto J Kaumann
5-Hydroxytryptamine-induced contraction of human temporal arteries coexpressing 5-HT2A receptors and wild-type or variant (Phe124Cys) 5-HT1B receptors: increased contribution of 5-HT1B receptors to the total contractile amplitude in arteries from Phe124Cys heterozygous individuals.
Pharmacogenetics and genomics 2006;16(8):601-7.
2006: Anne Amphoux; Vincent Vialou; Eva Drescher; Michael Brüss; Clotilde Mannoury La Cour; Catherine Rochat; Mark J Millan; Bruno GIROS; Heinz Bönisch; Sophie Gautron
Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain.
Neuropharmacology 2006;50(8):941-52.
2006: Gerhard J Molderings; Michael Brüss; Manfred Göthert
Functional and molecular identification of 5-hydroxytryptamine receptors in rabbit pulmonary artery: involvement in complex regulation of noradrenaline release.
Pharmacological reports : PR 2006;58(2):188-99.
2006: Martin Barann; Bernd Urban; Ulrike M Stamer; Zita Dorner; Heinz Bönisch; Michael Brüss
Effects of tramadol and O-demethyl-tramadol on human 5-HT reuptake carriers and human 5-HT3A receptors: a possible mechanism for tramadol-induced early emesis.
European journal of pharmacology 2006;531(1-3):54-8.
2006: Ralf Gilsbach; Mina Kouta; Heinz Bönisch; Michael Brüss
Comparison of in vitro and in vivo reference genes for internal standardization of real-time PCR data.
BioTechniques 2006;40(2):173-7.
2006: Ralf Gilsbach; Agata Faron-Górecka; Zofia Rogóz; Michael Brüss; Marc G Caron; Marta Dziedzicka-Wasylewska; Heinz Bönisch
Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors.
Journal of neurochemistry 2006;96(4):1111-20.
2006: Heinz Bönisch; Michael Brüss
The norepinephrine transporter in physiology and disease.
Handbook of experimental pharmacology 2006;(175):485-524.
2005: Jan Walkembach; Michael Brüss; Bernd W Urban; Martin Barann
Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.
British journal of pharmacology 2005;146(4):543-52.
2005: Michael Brüss; Sibylle Kiel; Heinz Bönisch; Arevat Kostanian; Manfred Göthert
Decreased agonist, but not antagonist, binding to the naturally occurring Thr92Lys variant of the h5-HT7(a) receptor.
Neurochemistry international 2005;47(3):196-203.
2005: Michael Brüss; Arevat Kostanian; Heinz Bönisch; Manfred Göthert
The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction.
Pharmacogenetics and genomics 2005;15(4):257-64.
2004: Felix Distelmaier; Philipp Wiedemann; Michael Brüss; Heinz Bönisch
Functional importance of the C-terminus of the human norepinephrine transporter.
Journal of neurochemistry 2004;91(3):537-46.
2004: Gerhard J Molderings; Bettina Kribben; Anja Heinen; Detlev Schröder; Michael Brüss; Manfred Göthert
Intestinal tumor and agmatine (decarboxylated arginine): low content in colon carcinoma tissue specimens and inhibitory effect on tumor cell proliferation in vitro.
Cancer 2004;101(4):858-68.
2004: Michael Brüss; Jürgen Homann; Gerhard J Molderings
[Dysferlinopathy as an extrahepatic cause for the elevation of serum transaminases].
Medizinische Klinik (Munich, Germany : 1983) 2004;99(6):326-9.
2004: Delia Kurzwelly; Martin Barann; Arevat Kostanian; Sandra Combrink; Heinz Bönisch; Manfred Göthert; Michael Brüss
Pharmacological and electrophysiological properties of the naturally occurring Pro391Arg variant of the human 5-HT3A receptor.
Pharmacogenetics 2004;14(3):165-72.
2004: Bettina Kribben; Jörg Heller; Jonel Trebicka; Tilman Sauerbruch; Michael Brüss; Manfred Göthert; Gerhard J Molderings
Agmatine (decarboxylated arginine), a modulator of liver cell homeostasis and proliferation.
Naunyn-Schmiedeberg's archives of pharmacology 2004;369(2):160-5.
2003: Anja Heinen; Michael Brüss; Heinz Bönisch; Manfred Göthert; Gerhard J Molderings
Pharmacological characteristics of the specific transporter for the endogenous cell growth inhibitor agmatine in six tumor cell lines.
International journal of colorectal disease 2003;18(4):314-9.
2003: Michael Brüss; Heinz Bönisch; Manfred Göthert; Gerhard J Molderings
Molecular structure of the rabbit alpha2A-adrenoceptor: a contribution to the alpha2A-adrenoceptor versus I1 imidazoline receptor controversy.
Naunyn-Schmiedeberg's archives of pharmacology 2003;367(3):328-31.
2003: Sibylle Kiel; Heinz Bönisch; Michael Brüss; Manfred Göthert
Impairment of signal transduction in response to stimulation of the naturally occurring Pro279Leu variant of the h5-HT7(a) receptor.
Pharmacogenetics 2003;13(2):119-26.
2002: Martin Barann; Gerhard J Molderings; Michael Brüss; Heinz Bönisch; Bernd W Urban; Manfred Göthert
Direct inhibition by cannabinoids of human 5-HT3A receptors: probable involvement of an allosteric modulatory site.
British journal of pharmacology 2002;137(5):589-96.
2002: Martina Hayer-Zillgen; Michael Brüss; Heinz Bönisch
Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
British journal of pharmacology 2002;136(6):829-36.
2002: P Wiedemann; Heinz Bönisch; F Oerters; Michael Brüss
Structure of the human histamine H3 receptor gene (HRH3) and identification of naturally occurring variations.
Journal of neural transmission (Vienna, Austria : 1996) 2002;109(4):443-53.
2002: Gerhard J Molderings; Heinz Bönisch; R Hammermann; Manfred Göthert; Michael Brüss
Noradrenaline release-inhibiting receptors on PC12 cells devoid of alpha(2(-)) and CB(1) receptors: similarities to presynaptic imidazoline and edg receptors.
Neurochemistry international 2002;40(2):157-67.
2001: Gerhard J Molderings; Heinz Bönisch; Manfred Göthert; Michael Brüss
Agmatine and putrescine uptake in the human glioma cell line SK-MG-1.
Naunyn-Schmiedeberg's archives of pharmacology 2001;363(6):671-9.
2000: Michael Brüss; Martin Barann; Martina Hayer-Zillgen; T Eucker; Manfred Göthert; Heinz Bönisch
Modified 5-HT3A receptor function by co-expression of alternatively spliced human 5-HT3A receptor isoforms.
Naunyn-Schmiedeberg's archives of pharmacology 2000;362(4-5):392-401.
2000: Sibylle Kiel; Michael Brüss; Heinz Bönisch; Manfred Göthert
Pharmacological properties of the naturally occurring Phe-124-Cys variant of the human 5-HT1B receptor: changes in ligand binding, G-protein coupling and second messenger formation.
Pharmacogenetics 2000;10(7):655-66.
2000: Martin Barann; Wolfgang P Meder; Z Dorner; Michael Brüss; Heinz Bönisch; Manfred Göthert; Bernd W Urban
Recombinant human 5-HT3A receptors in outside-out patches of HEK 293 cells: basic properties and barbiturate effects.
Naunyn-Schmiedeberg's archives of pharmacology 2000;362(3):255-65.
2000: Gerhard J Molderings; Heinz Bönisch; Michael Brüss; James A Likungu; Manfred Göthert
Species-specific pharmacological properties of human alpha(2A)-adrenoceptors.
Hypertension 2000;36(3):405-10.
2000: Fabian Runkel; Michael Brüss; Markus M Nöthen; Gerald Stöber; Peter Propping; Heinz Bönisch
Pharmacological properties of naturally occurring variants of the human norepinephrine transporter.
Pharmacogenetics 2000;10(5):397-405.
2000: Michael Brüss; T Eucker; Manfred Göthert; Heinz Bönisch
Exon-intron organization of the human 5-HT3A receptor gene.
Neuropharmacology 2000;39(2):308-15.
2000: A Wieland; Martina Hayer-Zillgen; Heinz Bönisch; Michael Brüss
Analysis of the gene structure of the human (SLC22A3) and murine (Slc22a3) extraneuronal monoamine transporter.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(10):1149-57.
1999: Heinz Bönisch; Fabian Runkel; Christine Roubert; Bruno GIROS; Michael Brüss
The human desipramine-sensitive noradrenaline transporter and the importance of defined amino acids for its function.
Journal of autonomic pharmacology 1999;19(6):327-33.
1999: M Hayer; Heinz Bönisch; Michael Brüss
Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1).
Annals of human genetics 1999;63(Pt 6):473-82.
1999: Martin Barann; Manfred Göthert; Michael Brüss; Heinz Bönisch
Inhibition by steroids of [14C]-guanidinium flux through the voltage-gated sodium channel and the cation channel of the 5-HT3 receptor of N1E-115 neuroblastoma cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(3):234-41.
1999: Michael Brüss; Gerhard J Molderings; Heinz Bönisch; Manfred Göthert
Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(3):225-33.
1999: Filip A Paczkowski; Lesley J Bryan-Lluka; P Pörzgen; Michael Brüss; Heinz Bönisch
Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.
The Journal of pharmacology and experimental therapeutics 1999;290(2):761-7.
1999: Manfred Göthert; Michael Brüss; Heinz Bönisch; Gerhard J Molderings
Presynaptic imidazoline receptors. New developments in characterization and classification.
Annals of the New York Academy of Sciences 1999;881():171-84.
1999: Gerald Stöber; Johannes Hebebrand; Sven Cichon; Michael Brüss; Heinz Bönisch; Gerd Lehmkuhl; Fritz Poustka; M Schmidt; Helmut Remschmidt; Peter Propping; Markus M Nöthen
Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening.
American journal of medical genetics 1999;88(2):158-63.
1999: Michael Brüss; Heinz Bönisch; M Bühlen; Markus M Nöthen; Peter Propping; Manfred Göthert
Modified ligand binding to the naturally occurring Cys-124 variant of the human serotonin 5-HT1B receptor.
Pharmacogenetics 1999;9(1):95-102.
1999: Michael Brüss; A Wieland; Heinz Bönisch
Molecular cloning and functional expression of the mouse dopamine transporter.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(7-8):657-62.
1998: Michael Brüss; Manfred Göthert; M Hayer; Heinz Bönisch
Molecular cloning of alternatively spliced human 5-HT3 receptor cDNAs.
Annals of the New York Academy of Sciences 1998;861():234-5.
1998: Manfred Göthert; Peter Propping; Heinz Bönisch; Michael Brüss; Markus M Nöthen
Genetic variation in human 5-HT receptors: potential pathogenetic and pharmacological role.
Annals of the New York Academy of Sciences 1998;861():26-30.
1998: Michael Brüss; Heinz Bönisch
Anticancer therapy-induced emesis: existence of an intestinal subtype of the 5-HT3 receptor?
Gastroenterology 1998;115(6):1606-7.
1998: P Pörzgen; Heinz Bönisch; R Hammermann; Michael Brüss
The human noradrenaline transporter gene contains multiple polyadenylation sites and two alternatively spliced C-terminal exons.
Biochimica et biophysica acta 1998;1398(3):365-70.
1998: Jobst Meyer; P Wiedemann; Olga Okladnova; Michael Brüss; T Staab; Gerald Stöber; Peter Riederer; Heinz Bönisch; Klaus-Peter Lesch
Cloning and functional characterization of the human norepinephrine transporter gene promoter.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(10-12):1341-50.
1998: Heinz Bönisch; R Hammermann; Michael Brüss
Role of protein kinase C and second messengers in regulation of the norepinephrine transporter.
Advances in pharmacology (San Diego, Calif.) 1998;42():183-6.
1997: Michael Brüss; P Pörzgen; Lesley J Bryan-Lluka; Heinz Bönisch
The rat norepinephrine transporter: molecular cloning from PC12 cells and functional expression.
Brain research. Molecular brain research 1997;52(2):257-62.
1996: Gerald Stöber; Markus M Nöthen; P Pörzgen; Michael Brüss; Heinz Bönisch; Michael Knapp; Helmut Beckmann; Peter Propping
Systematic search for variation in the human norepinephrine transporter gene: identification of five naturally occurring missense mutations and study of association with major psychiatric disorders.
American journal of medical genetics 1996;67(6):523-32.
1996: P Pörzgen; Heinz Bönisch; Michael Brüss
Molecular cloning and organization of the coding region of the human norepinephrine transporter gene.
Biochemical and biophysical research communications 1996;227(2):642-3.
1996: S Streich; Michael Brüss; Heinz Bönisch
Expression of the extraneuronal monoamine transporter (uptake2) in human glioma cells.
Naunyn-Schmiedeberg's archives of pharmacology 1996;353(3):328-33.
1995: P Pörzgen; Heinz Bönisch; Michael Brüss
Molecular cloning and organization of the coding region of the human norepinephrine transporter gene.
Biochemical and biophysical research communications 1995;215(3):1145-50.
1995: Michael Brüss; M Bühlen; J Erdmann; Manfred Göthert; Heinz Bönisch
Binding properties of the naturally occurring human 5-HT1A receptor variant with the Ile28Val substitution in the extracellular domain.
Naunyn-Schmiedeberg's archives of pharmacology 1995;352(4):455-8.
1995: Michael Brüss; R Hammermann; Stephen Brimijoin; Heinz Bönisch
Antipeptide antibodies confirm the topology of the human norepinephrine transporter.
The Journal of biological chemistry 1995;270(16):9197-201.
1994: Heinz Bönisch; Michael Brüss
The noradrenaline transporter of the neuronal plasma membrane.
Annals of the New York Academy of Sciences 1994;733():193-202.
1994: B Lingen; Michael Brüss; Heinz Bönisch
Cloning and expression of the bovine sodium- and chloride-dependent noradrenaline transporter.
FEBS letters 1994;342(3):235-8.
1993: Michael Brüss; Juergen Kunz; B Lingen; Heinz Bönisch
Chromosomal mapping of the human gene for the tricyclic antidepressant-sensitive noradrenaline transporter.
Human genetics 1993;91(3):278-80.